FDA Import Refusal 799-7025460-3/51/1 — ZHEJIANG DONGRI PHARMACEUTICAL C
The FDA refused shipment 799-7025460-3/51/1 from ZHEJIANG DONGRI PHARMACEUTICAL C (China) on Oct 17, 2023. The refused product falls under Drugs and Biologics — AMPICILLIN (PENICILLIN, SYNTHETICALLY PRODUCED). Cited charges: 118,3280,75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Oct 17, 2023
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 56BDB05 AMPICILLIN (PENICILLIN, SYNTHETICALLY PRODUCED)
- Charges
- 118,3280,75